Literature DB >> 3223231

Reduced prealbumin (transthyretin) in CSF of severely demented patients with Alzheimer's disease.

H Riisøen1.   

Abstract

Prealbumin (transthyretin) quantified in CSF was negatively correlated with degree of dementia in 24 patients with dementia of Alzheimer type (DAT). There was neither a significant correlation between prealbumin in serum and degree of dementia nor between prealbumin in CSF and number of T lymphocytes in serum. There was no such relationship in 7 patients with multi-infarct dementia. Prealbumin was also quantified in 4 non-demented control groups, one consisting of 14 age- and sex-matched neurological patients, 17 with MS, 6 with ALS and 10 patients who had had a subarachnoid hemorrhage. Prealbumin was significantly lower in the last group. The study suggests that there may be a relationship between prealbumin levels in cerebrospinal fluid and degree of dementia. It is suggested that this may be caused by affection of the choroid plexus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3223231     DOI: 10.1111/j.1600-0404.1988.tb03687.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  25 in total

1.  Why should plasma transthyretin become a routine screening tool in elderly persons?

Authors:  Y Ingenbleek
Journal:  J Nutr Health Aging       Date:  2009-08       Impact factor: 4.075

2.  Thyroid hormone levels in the prefrontal cortex of post-mortem brains of Alzheimer's disease patients.

Authors:  Jennifer Duncan Davis; Anna Podolanczuk; John E Donahue; Edward Stopa; James V Hennessey; Lu-Guong Luo; Yow-Pin Lim; Robert A Stern
Journal:  Curr Aging Sci       Date:  2008-12

Review 3.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

4.  Mechanisms of transthyretin inhibition of β-amyloid aggregation in vitro.

Authors:  Xinyi Li; Xin Zhang; Ali Reza A Ladiwala; Deguo Du; Jay K Yadav; Peter M Tessier; Peter E Wright; Jeffery W Kelly; Joel N Buxbaum
Journal:  J Neurosci       Date:  2013-12-11       Impact factor: 6.167

5.  Cerebrospinal Fluid Proteins as Regulators of Beta-amyloid Aggregation and Toxicity.

Authors:  Kayla M Pate; Regina M Murphy
Journal:  Isr J Chem       Date:  2017-01-18       Impact factor: 3.333

6.  Transthyretin sequesters amyloid beta protein and prevents amyloid formation.

Authors:  A L Schwarzman; L Gregori; M P Vitek; S Lyubski; W J Strittmatter; J J Enghilde; R Bhasin; J Silverman; K H Weisgraber; P K Coyle
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

7.  HOTMAQ: A Multiplexed Absolute Quantification Method for Targeted Proteomics.

Authors:  Xiaofang Zhong; Qinying Yu; Fengfei Ma; Dustin C Frost; Lei Lu; Zhengwei Chen; Henrik Zetterberg; Cynthia Carlsson; Ozioma Okonkwo; Lingjun Li
Journal:  Anal Chem       Date:  2019-01-18       Impact factor: 6.986

8.  Rare Genetic Variants of the Transthyretin Gene Are Associated with Alzheimer's Disease in Han Chinese.

Authors:  Qun Xiang; Rui Bi; Min Xu; Deng-Feng Zhang; Liwen Tan; Chen Zhang; Yiru Fang; Yong-Gang Yao
Journal:  Mol Neurobiol       Date:  2016-08-25       Impact factor: 5.590

9.  Antibodies to choroid plexus in senile dementia of Alzheimer's type.

Authors:  J M Serot; M C Béné; B Gobert; D Christmann; B Leheup; G C Faure
Journal:  J Clin Pathol       Date:  1992-09       Impact factor: 3.411

10.  Mobile and cordless telephones, serum transthyretin and the blood-cerebrospinal fluid barrier: a cross-sectional study.

Authors:  Fredrik Söderqvist; Michael Carlberg; Lennart Hardell
Journal:  Environ Health       Date:  2009-04-21       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.